Deep learning with feature embedding for compound-protein interaction prediction
Preprint
Abstract
Accurately identifying compound-protein interactions in silico can deepen our understanding of the mechanisms of drug action and significantly facilitate the drug discovery and development process. Traditional similarity-based computational models for compound-protein interaction prediction rarely exploit the latent features from current available large-scale unlabelled compound and protein data, and often limit their usage on relatively small-scale datasets. We propose a new scheme that combines feature embedding (a technique of representation learning) with deep learning for predicting compound-protein interactions. Our method automatically learns the low-dimensional implicit but expressive features for compounds and proteins from the massive amount of unlabelled data. Combining effective feature embedding with powerful deep learning techniques, our method provides a general computational pipeline for accurate compound-protein interaction prediction, even when the interaction knowledge of compounds and proteins is entirely unknown. Evaluations on current large-scale databases of the measured compound-protein affinities, such as ChEMBL and BindingDB, as well as known drug-target interactions from DrugBank have demonstrated the superior prediction performance of our method, and suggested that it can offer a useful tool for drug development and drug repositioning.Keywords
This publication has 48 references indexed in Scilit:
- DrugE-Rank: improving drug–target interaction prediction of new candidate drugs or targets by ensemble learning to rankBioinformatics, 2016
- Large-scale Direct Targeting for Drug Repositioning and DiscoveryScientific Reports, 2015
- Ligand-Target Prediction by Structural Network Biology Using nAnnoLyzePLOS Computational Biology, 2015
- Shifting from the single to the multitarget paradigm in drug discoveryDrug Discovery Today, 2013
- Large-scale prediction and testing of drug activity on side-effect targetsNature, 2012
- Diagnosing the decline in pharmaceutical R&D efficiencyNature Reviews Drug Discovery, 2012
- Predicting new molecular targets for known drugsNature, 2009
- Repurposing libraries of eukaryotic protein kinase inhibitors for antibiotic discoveryProceedings of the National Academy of Sciences, 2009
- A class of selective antibacterials derived from a protein kinase inhibitor pharmacophoreProceedings of the National Academy of Sciences, 2009
- Relating protein pharmacology by ligand chemistryNature Biotechnology, 2007